DCM
KRTX

DAFNA Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

DAFNA Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-48,145
Closed -$15.2M – 84
2023
Q4 		$15.2M Sell
48,145
-4,728
-9% -$919K 3.65% 7
2023
Q3 		$8.94M Buy
52,873
+10,700
+25% +$2.01M 2.78% 11
2023
Q2 		$9.15M Sell
42,173
-36,400
-46% -$7.8M 2.5% 14
2023
Q1 		$14.3M Buy
78,573
+6,546
+9% +$1.25M 4.28% 5
2022
Q4 		$14.2M Buy
72,027
+43,141
+149% +$9.25M 3.99% 4
2022
Q3 		$6.5M Sell
28,886
-33,167
-53% -$6.71M 1.75% 19
2022
Q2 		$7.85M Sell
62,053
-20,000
-24% -$2.3M 2.14% 12
2022
Q1 		$10.4M Buy
82,053
+9,630
+13% +$1.08M 2.71% 8
2021
Q4 		$9.49M Sell
72,423
-2,162
-3% -$279K 2.39% 9
2021
Q3 		$9.12M Buy
74,585
+21,585
+41% +$2.49M 2.42% 10
2021
Q2 		$6.04M Buy
53,000
+5,000
+10% +$584K 1.26% 23
2021
Q1 		$5.77M Buy
48,000
+31,332
+188% +$3.55M 1.37% 19
2020
Q4 		$1.69M Buy
16,668
+7,437
+81% +$689K 0.5% 45
2020
Q3 		$714K Hold
9,231
– – 0.23% 66
2020
Q2 		$1.03M Buy
9,231
+3,000
+48% +$261K 0.3% 56
2020
Q1 		$449K Buy
+6,231
New +$533K 0.19% 67
2019
Q4 		– Sell
-11,192
Closed -$183K – 91
2019
Q3 		$183K Buy
11,192
+1,192
+12% +$23.2K 0.07% 84
2019
Q2 		$200K Buy
+10,000
New +$200K 0.08% 81

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

DAFNA Capital Management's KRTX Position: Q1 2024 in Review

DAFNA Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 48,145 shares — an estimated $15.2M sold.

DAFNA Capital Management first reported a position in KRTX in Q2 2019 and held it in 18 quarters. The position peaked at $15.2M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • DAFNA Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • DAFNA Capital Management sold 48,145 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $15.2M.
  • DAFNA Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2019 and held it in 18 quarters.
  • DAFNA Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $15.2M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on DAFNA Capital Management's 13F filing for Q1 2024, filed 15 May 2024.